Come up with a name for your new list and we'll add to it:
Metheor Therapeutics raised a round of funding on August 30, 2011. Investors include
Washington Biotechnology Funding.
Metheor Therapeutics focuses on inhibitors of human DNA Methyltransferases (DNMTs). Using rational design methods and medicinal chemistry, the company is working to introduce small molecule compounds …